Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients

Overview of attention for article published in BMC Infectious Diseases, March 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

policy: 1 policy source
twitter: 3 X users

patent: 2 patents

Citations

dimensions_citation: 77 Dimensions

Readers on

mendeley: 142 Mendeley

Summary Policy documents X Patents Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,127 followers.

@dredgarbarragan @sidvimx El beneficio no solo es para los usuarios naive, sino también para pacientes indetectables con un esquema previo, manteniendo así la supresión virológica #diplomadomarte SYOE. https://t.co/OBOY3FmjqO

22 Aug 2021

Reply Repost Favourite

y el beneficio no solo es para pacientes naive, si no como alternativas a pacientes tratados con un esquema previo: mantiene supresion virologica, disminuye interacciones medicamentosas, disminuye riesgo de resistencia @sidvimx AIGS #Aton https://t.co/ED

19 Jan 2021

Reply Repost Favourite

Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients https://t.co/cQ8rqAJfG5 #bmcinfectdis

22 Mar 2017

Reply Repost Favourite